Greater Baltimore Medical Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1974
NCT00000491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Greater Baltimore Medical Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 3)

Coronary Disease (Phase 3)

Cystadenocarcinoma, Serous (Phase 3)

Death, Sudden (Phase 3)

Death, Sudden, Cardiac (Phase 3)

Heart Diseases (Phase 3)

Infarction (Phase 3)

Ischemia (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Uterine Neoplasms (Phase 3)

Ventricular Fibrillation (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4